Nuclear Medicine Imaging Equipment MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy ConfigurationBy End UserBy Component

Nuclear medicine imaging equipment covers the scanners used to visualize physiological and metabolic activity inside the body by detecting radiation emitted from a small dose of radioactive tracer administered to the patient, most commonly positron emission tomography (PET) systems sold as standalone units or combined with computed tomography or magnetic resonance imaging in a single hybrid system. Buyers are hospitals, dedicated diagnostic imaging centers and academic or research medical centers that use these scans primarily to stage and monitor cancer treatment, alongside smaller volumes of cardiac and neurological studies.

Growth of 8.51% a year carries the global nuclear medicine imaging equipment market from USD 6.9 billion in 2025 to USD 14.31 billion in 2034. The full series behind that rate covers USD 4.7 billion in 2020, USD 6.39 billion in 2024, USD 7.45 billion in 2026 and USD 10.32 billion in 2030, with 2025 as the base year.

On the type axis, growth rates run from 7.67% for Full Ring PET Scanners up to 10.13% for Partial Ring PET Scanners. Full Ring PET Scanners carries the volume: USD 4.69 billion and 68% of revenue in 2025, USD 9.16 billion and 64% in 2034. The lines gaining share are Partial Ring PET Scanners. Full Ring PET Scanners lose share without losing revenue.

By application, Oncology accounts for 62% of 2025 revenue at USD 4.28 billion, reaching USD 9.3 billion and 65% by 2034. It is also the fastest-growing line on this axis at 9%, so the split concentrates over the period instead of balancing. This axis divides the same revenue as the type split instead of adding to it, so the two are read together and never summed.

North America is the largest region at 38% of 2025 revenue, worth USD 2.62 billion and reaching USD 4.87 billion by 2034. Europe follows at 27%, moving from USD 1.86 billion to USD 3.58 billion, and Middle East and Africa is the smallest at 5.1%. Because Asia Pacific take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

Behind these figures sit five regions, two type lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the same applies to the segment, regional and country breakdowns drawn from it.

• A forecast-period rate of 8.51% takes the market from USD 6.9 billion in 2025 to USD 14.31 billion in 2034, against 7.98% recorded over the 2020-2025 historical period.
• The largest line by type is Full Ring PET Scanners, worth USD 4.69 billion and 68% of revenue in 2025, rising to USD 9.16 billion and 64% by 2034.
• At 10.13%, Partial Ring PET Scanners grows faster than any other type line, moving from USD 2.21 billion and 32% of revenue in 2025 to USD 5.15 billion and 36% in 2034.
• Scenario range for 2034 runs from USD 12.16 billion in the bear case to USD 16.46 billion in the bull case, against a base-case USD 14.31 billion, the spread a plan built on this forecast has to absorb.
• North America holds 38% of global revenue in 2025 at USD 2.62 billion, the largest of the five regions tracked, and reaches USD 4.87 billion by 2034.
• The United States accounts for 85.1% of North America in the base year, worth USD 2.23 billion in 2025 and reaching USD 4.14 billion by 2034, the worked country example carried through that region's chapters.
• The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and five segmentation axes separately, with revenue, share and a growth rate for every line in each year.

The global nuclear medicine imaging equipment market is shaped over 2026-2034 by three measurable movements: a change in the type mix, a shift in where revenue sits geographically, and the 8.51% rate carrying the total.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

Composition shifts on the type axis. Partial Ring PET Scanners grows at 10.13% across 2026-2034 against 7.67% for Full Ring PET Scanners, the widest spread on the type axis. Over the forecast period that moves Partial Ring PET Scanners from 32% of revenue to 36%, and Full Ring PET Scanners from 68% to 64%. Neither contracts: USD 2.21 billion becomes USD 5.15 billion, USD 4.69 billion becomes USD 9.16 billion. What the spread decides is which of them a supplier's revenue is exposed to.

Growth concentrates in Asia Pacific. Asia Pacific moves from 24.1% of revenue in 2025 to 30% in 2034, worth USD 1.66 billion rising to USD 4.29 billion. The remaining regions grow in absolute terms while giving up share: North America at 38% moving to 34%, Europe at 27% moving to 25%, Latin America at 5.9% moving to 5.9%, Middle East and Africa at 5.1% moving to 5%. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

Growth compounds at 8.51% without a step change. Fifteen years of revenue run USD 4.7 billion in 2020, USD 6.39 billion in 2024, USD 6.9 billion in 2025, USD 7.45 billion in 2026, USD 10.32 billion in 2030 and USD 14.31 billion in 2034. There is no discontinuity to time, and 8.51% forecast growth against 7.98% historical means the trend continues and does not turn. For a participant that makes planning a question of capturing a share of steady expansion instead of timing a discontinuity, and it is why the type and regional mixes matter more to a forecast than the headline rate does.

Growth is concentrated in Partial Ring PET Scanners

Separate the 8.51% into its parts and three show up: an already-large base compounding, the type mix moving toward its faster lines, and regional growth landing unevenly.

What holds the forecast back

Upside case: USD 16.46 billion by 2034

Revenue is concentrated in Full Ring PET Scanners

USD 2.62 billion of 2025 revenue is generated in North America, 38% of the global nuclear medicine imaging equipment market rising to USD 4.87 billion in 2034. Among the five regions it ranks first by revenue in both years.

Its share moves to 34% by 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Within the region the type split tracks the global one; 68% of 2025 revenue in Full Ring PET Scanners, fastest growth of 10.13% in Partial Ring PET Scanners. The full report breaks North America out along every axis and by country.

USD 2.23 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 4.14 billion by 2034. At 85.1% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. The region itself runs USD 2.62 billion to USD 4.87 billion over the same period, and this is the market carrying the country-level detail in the full report.

the United States buys along the same lines as the market globally; Full Ring PET Scanners first at 68% of 2025 revenue and 64% in 2034, Partial Ring PET Scanners fastest at 10.13% on a share moving from 32% to 36%. Its 85.1% weight in North America means those movements carry straight into the regional totals. Revenue by type for the United States is reported separately in the full report.

Nuclear medicine imaging equipment sold in the United States is regulated by the Food and Drug Administration under its medical device framework, administered through the Center for Devices and Radiological Health. A gamma camera, SPECT or PET system is classified according to its risk profile, and most such systems reach the market through the premarket notification pathway by demonstrating substantial equivalence to a predicate device already cleared for sale. Manufacturers must also meet the agency's performance standards for radiation-emitting products, covering aspects such as dose output and shielding. Facilities operating this equipment fall under additional oversight from state radiation control programs and, where radioactive materials are involved, from the Nuclear Regulatory Commission. Labelling must disclose intended use, operating parameters and safety warnings clearly enough for a qualified operator to rely on.

Digirad Corp. (US), Philips Healthcare (US), GE Healthcare Plc (UK), Mediso Medical Imaging Systems (Hungary), Siemens Healthineers (Germany) and Positron Corporation (US) are the suppliers covered in the United States. Full Ring PET Scanners, at 68% of 2025 revenue, is where the volume sits, and Partial Ring PET Scanners, growing at 10.13%, is where position changes hands over the forecast period. The full report covers country-level positioning and shares company by company; this summary does not.

Within North America, Canada accounts for 14.5% of regional revenue and 5.5% of the global total, worth USD 0.38 billion in 2025 and USD 0.72 billion by 2034.

27% of the global nuclear medicine imaging equipment market sits in Europe in 2025, worth USD 1.86 billion with USD 3.58 billion projected for 2034. Among the five regions it ranks second by revenue in both years.

25% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

Segment composition follows the global pattern: Full Ring PET Scanners largest at 68% of 2025 revenue, Partial Ring PET Scanners fastest at 10.13%. Europe is reported axis by axis and country by country in the full study.

USD 0.56 billion of Europe's 2025 revenue is generated in Germany, the region's largest market, reaching USD 1.07 billion by 2034. At 30.1% of the region in 2025 it leads, but a majority of Europe's revenue is generated in other markets. The region itself runs USD 1.86 billion to USD 3.58 billion over the same period, and this is the market carrying the country-level detail in the full report.

The type pattern in Germany is the global one: 68% of 2025 revenue in Full Ring PET Scanners, 64% by 2034, against 10.13% growth in Partial Ring PET Scanners taking it from 32% to 36%. Since 30.1% of Europe's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Germany carries its own type breakdown in the full report.

As a European Union member state, Germany regulates nuclear medicine imaging equipment under the EU Medical Device Regulation, which classifies such systems according to their risk and function and requires conformity assessment before a CE mark can be applied. A notified body, often operating within Germany itself, reviews technical documentation, quality management systems and clinical evaluation evidence for higher-risk imaging devices. The Federal Institute for Drugs and Medical Devices oversees market surveillance and vigilance reporting once a device is placed on the German market. Because these systems involve ionising radiation, installations must also satisfy national radiation protection law, which governs licensing of the equipment's use and the training of operating personnel. Labelling and instructions for use must appear in German and follow the harmonised standards referenced under the Regulation.

In Germany the field is Digirad Corp. (US), Philips Healthcare (US), GE Healthcare Plc (UK), Mediso Medical Imaging Systems (Hungary), Siemens Healthineers (Germany) and Positron Corporation (US). Volume sits in Full Ring PET Scanners at 68% of 2025 revenue; movement sits in Partial Ring PET Scanners at 10.13% growth. The commercial size of that position is USD 1.86 billion in 2025 and USD 3.58 billion by 2034, 27% of the global total in the base year.

Within Europe, the United Kingdom accounts for 22% of regional revenue and 5.9% of the global total, worth USD 0.41 billion in 2025 and USD 0.79 billion by 2034.

France is sized at USD 0.33 billion in 2025, rising to USD 0.64 billion by 2034; 4.8% of global revenue and 17.7% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

USD 1.66 billion of 2025 revenue is generated in Asia Pacific, 24.1% of the global nuclear medicine imaging equipment market and reaches USD 4.29 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

Share climbs to 30% by 2034, on growth above the market's own 8.51%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Segment composition follows the global pattern: Full Ring PET Scanners largest at 68% of 2025 revenue, Partial Ring PET Scanners fastest at 10.13%. Per-axis and per-country detail for Asia Pacific sits in the full report.

China is the largest market within Asia Pacific, generating USD 0.66 billion in 2025 and projected to reach USD 1.72 billion by 2034. Its 39.8% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Regional revenue of USD 1.66 billion in 2025 and USD 4.29 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

China buys along the same lines as the market globally; Full Ring PET Scanners first at 68% of 2025 revenue and 64% in 2034, Partial Ring PET Scanners fastest at 10.13% on a share moving from 32% to 36%. Since 39.8% of Asia Pacific's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. China carries its own type breakdown in the full report.

Nuclear medicine imaging equipment in China is regulated by the National Medical Products Administration, which classifies medical devices by risk and assigns imaging systems of this kind to its higher classification tier given their reliance on ionising radiation and diagnostic function. A supplier must obtain registration approval from the agency before marketing such a device, supported by technical files, clinical evaluation data and manufacturing quality certification aligned with national good manufacturing practice requirements. Because these systems emit or rely on radioactive materials, additional licensing from health and radiation safety authorities applies to their installation and operation within hospitals. Imported systems generally face a more demanding registration route than domestically produced equivalents, and labelling must be presented in Chinese with instructions that meet the administration's format requirements.

Digirad Corp. (US), Philips Healthcare (US), GE Healthcare Plc (UK), Mediso Medical Imaging Systems (Hungary), Siemens Healthineers (Germany) and Positron Corporation (US) are the suppliers covered in China. Full Ring PET Scanners, at 68% of 2025 revenue, is where the volume sits, and Partial Ring PET Scanners, growing at 10.13%, is where position changes hands over the forecast period. A supplier weighted toward Asia Pacific is competing over a base of USD 1.66 billion in 2025 reaching USD 4.29 billion by 2034, 24.1% of global revenue at the start of that period.

7.2% of global revenue is generated in Japan; USD 0.5 billion in 2025, reaching USD 1.29 billion in 2034, and 30.1% of Asia Pacific.

India is sized at USD 0.25 billion in 2025, rising to USD 0.64 billion by 2034; 3.6% of global revenue and 15.1% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

In Latin America, 5.9% of global revenue puts 2025 at USD 0.41 billion and reaches USD 0.85 billion by 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

By 2034 the share stands at 5.9%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Full Ring PET Scanners leads here as it does globally, at 68% of 2025 revenue, and Partial Ring PET Scanners again grows fastest at 10.13%. The full report breaks Latin America out along every axis and by country.

Brazil is the largest market within Latin America, generating USD 0.23 billion in 2025 and projected to reach USD 0.47 billion by 2034. At 56.1% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. Against regional totals of USD 0.41 billion in 2025 and USD 0.85 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Full Ring PET Scanners at 68% of 2025 revenue, easing to 64% by 2034, and the fastest is Partial Ring PET Scanners at 10.13%, from 32% to 36%. Because the country carries 56.1% of Latin America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-type revenue for Brazil appears on its own in the full report.

In Brazil, nuclear medicine imaging equipment falls under the authority of the National Health Surveillance Agency, known as Anvisa, which treats such systems as medical devices requiring registration before commercial distribution. Classification follows a risk-based scheme, and imaging equipment of this kind typically requires a more rigorous technical dossier covering safety, performance and quality system compliance, often assessed against Brazil's own good manufacturing practice certification for the manufacturing site. Because the equipment involves ionising radiation, its installation and use are additionally subject to oversight from the national nuclear energy authority, which licenses radiation sources and inspects facilities. Portuguese-language labelling and user documentation are required, and any post-market safety issue must be reported to Anvisa under its vigilance system.

In Brazil the field is Digirad Corp. (US), Philips Healthcare (US), GE Healthcare Plc (UK), Mediso Medical Imaging Systems (Hungary), Siemens Healthineers (Germany) and Positron Corporation (US). The commercially relevant division is 68% of 2025 revenue in Full Ring PET Scanners, where the volume is, against 10.13% growth in Partial Ring PET Scanners, where share moves. That makes Latin America a 5.9% share of 2025 global revenue, USD 0.41 billion rising to USD 0.85 billion, for any supplier deciding where to concentrate.

Mexico is sized at USD 0.15 billion in 2025, rising to USD 0.3 billion by 2034; 2.2% of global revenue and 36.6% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

Middle East and Africa holds 5.1% of the global nuclear medicine imaging equipment market in 2025, worth USD 0.35 billion and reaches USD 0.72 billion by 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

Its share moves to 5% by 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Segment composition follows the global pattern: Full Ring PET Scanners largest at 68% of 2025 revenue, Partial Ring PET Scanners fastest at 10.13%. The full report breaks Middle East and Africa out along every axis and by country.

USD 0.12 billion of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 0.25 billion by 2034. At 34.3% of the region in 2025 it leads, but a majority of Middle East and Africa's revenue is generated in other markets. Regional revenue of USD 0.35 billion in 2025 and USD 0.72 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Saudi Arabia buys along the same lines as the market globally; Full Ring PET Scanners first at 68% of 2025 revenue and 64% in 2034, Partial Ring PET Scanners fastest at 10.13% on a share moving from 32% to 36%. Its 34.3% weight in Middle East and Africa means those movements carry straight into the regional totals. Revenue by type for Saudi Arabia is reported separately in the full report.

The Saudi Food and Drug Authority governs the registration and market entry of nuclear medicine imaging equipment in Saudi Arabia, applying a medical device classification system that treats such imaging systems according to their risk and diagnostic role. A supplier must register the device and its manufacturing facility with the authority, providing evidence of conformity to recognised international safety and performance standards before the equipment can be marketed or installed. Given the use of ionising radiation, separate licensing from the kingdom's nuclear and radiological regulatory body applies to facilities that install and operate the equipment, covering shielding, staff training and ongoing safety inspection. Labelling and instructions for use must be provided in Arabic alongside any other language used, and importers are expected to maintain a local authorised representative for regulatory correspondence.

Competition in Saudi Arabia runs between the suppliers this study tracks: Digirad Corp. (US), Philips Healthcare (US), GE Healthcare Plc (UK), Mediso Medical Imaging Systems (Hungary), Siemens Healthineers (Germany) and Positron Corporation (US). The commercially relevant division is 68% of 2025 revenue in Full Ring PET Scanners, where the volume is, against 10.13% growth in Partial Ring PET Scanners, where share moves. The commercial size of that position is USD 0.35 billion in 2025 and USD 0.72 billion by 2034, 5.1% of the global total in the base year.

1.3% of global revenue is generated in South Africa; USD 0.09 billion in 2025, reaching USD 0.18 billion in 2034, and 25.7% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by type, application, configuration, end user, component, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.